A study to compare the effect of pushkaramoola arka and bharangi arka nebulization in asthma

A comparative clinical study to evaluate the therapeutic effect of pushkaramoola arka and bharangi arka nebulization in management of tamaka shwasa - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/083764

Enrollment

Registered

2025-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having a history of more than 3 months of mild to moderate exacerbation of bronchial asthma. FEV1-60-79%-mild. And FEVI-40-59%-moderate. Patient with vitals-B.P-118-148/80-90 mm/hg, SpO2-84-99% @ RA, HR-68-110bpm, R.R-18-38cycles/min.

Exclusion criteria

Exclusion criteria: Severe Exacerbation bronchial asthma Asadhya lakshanas of Tamaka Sihwasa Tamak shwasa associated complaints like Emphysema, Cor Pulmonale, Tuberculosis, CHF, and Chronic airway limitations. Pregnant and lactating women. Patients with uncontrolled HTN, T2DM, and systemic illness.

Design outcomes

Primary

Measure	Time frame
To reduce the congestion AND Chest muscle relaxationTimepoint: each day 2 timed for 5 days	—

Secondary

Measure	Time frame
to reduce other symptomsTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDrRashmi Kalkura

Muniyal Institute of Ayurveda Medical Science Manipal

pramodshetb@gmail.com7204557179

Outcome results